These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 167492

  • 1. Lipoprotein binding and hypertriglyceridemia in chronic uremia.
    Samar RE, Moncrief JW, Decherd JF, Popovich RP.
    Trans Am Soc Artif Intern Organs; 1975; 21():455-63. PubMed ID: 167492
    [No Abstract] [Full Text] [Related]

  • 2. Lipoprotein metabolism in patients with chronic uremia. Effect of hemodialysis on serum lipoproteins and postheparin plasma triglyceride lipases.
    Huttunen JK, Pasternack A, Vänttinen T, Ehnholm C, Nikkilä EA.
    Acta Med Scand; 1978; 204(3):211-8. PubMed ID: 211802
    [No Abstract] [Full Text] [Related]

  • 3. Lipoprotein profile in dialysis and transplant patients.
    Lau YK, Woo KT, Lim CH.
    Singapore Med J; 1985 Apr; 26(2):193-7. PubMed ID: 3898396
    [No Abstract] [Full Text] [Related]

  • 4. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R, Frey F, Flury W, Klose G, Greten H.
    N Engl J Med; 1977 Dec 22; 297(25):1362-6. PubMed ID: 200841
    [Abstract] [Full Text] [Related]

  • 5. Abnormal fat metabolism in chronic renal failure.
    Romics L, Makó J.
    Acta Med Acad Sci Hung; 1978 Dec 22; 35(3-4):233-40. PubMed ID: 227218
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of lipoprotein abnormalities in patients with peripheral vascular disease.
    Ballantyne D, Lawrie TD, Morgan HG.
    Ann Biol Clin (Paris); 1973 Dec 22; 31(2):145-6. PubMed ID: 4356111
    [No Abstract] [Full Text] [Related]

  • 7. Longitudinal study on hyperlipidaemia and diet in RDT patients.
    Palmo A, Boggio-Bertinet D, Balzola F, Stratta P, Triolo G, Alloatti S, Bosticardo G, Giacchino F, Pagano GF, Levis F.
    Minerva Nefrol; 1982 Dec 22; 29(1):29-35. PubMed ID: 7048140
    [No Abstract] [Full Text] [Related]

  • 8. [Serum lipids levels, lipoprotein phenotypes and analysis of lipoprotein in Italian population group (author's transl)].
    Avogaro P, Cazzolato G, Capri C, Pais M, Trabuio GF.
    G Ital Cardiol; 1974 Dec 22; 4(2):237-48. PubMed ID: 4365662
    [No Abstract] [Full Text] [Related]

  • 9. Hyperlipoproteinemia type IV and pre-beta-lipoprotein. Some new aspects of its physiology, pathogenesis and diagnosis.
    Wille LE.
    J Oslo City Hosp; 1972 Dec 22; 22(11):169-84. PubMed ID: 4344735
    [No Abstract] [Full Text] [Related]

  • 10. [Plasma glycosaminoglycans in patients with coronary disease and hyperlipidemia].
    Giannini SD, Strunz CM, Forti N, Credidio Rde A, Diament J, Dereviacki BE, de Góis JM, de Serro-Azul LG.
    Arq Bras Cardiol; 1986 May 22; 46(5):307-10. PubMed ID: 3471185
    [No Abstract] [Full Text] [Related]

  • 11. On the relationship between Lp(a) lipoprotein, "sinking pre-beta-lipoprotein" and inherited hyper-beta-lipoproteinaemia.
    Heiberg A, Berg K.
    Clin Genet; 1974 May 22; 5(2):144-56. PubMed ID: 4364245
    [No Abstract] [Full Text] [Related]

  • 12. [Lipid composition of circulating lipoproteins in various types of hyperlipoproteinemia (author's transl)].
    Jaillard J, Sezille G, Dewailly P, Fruchart JC.
    Diabete Metab; 1977 Sep 22; 3(3):159-64. PubMed ID: 199484
    [Abstract] [Full Text] [Related]

  • 13. Serum lipid and lipoprotein concentrations in chronic uremia.
    Norbeck HE, Orö L, Carlson LA.
    Acta Med Scand; 1976 Sep 22; 200(6):487-92. PubMed ID: 189577
    [Abstract] [Full Text] [Related]

  • 14. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C, Tremblay M, Fredenrich A, Davignon J, Cohn JS.
    Metabolism; 2001 Jan 22; 50(1):112-9. PubMed ID: 11172484
    [Abstract] [Full Text] [Related]

  • 15. [Differential diagnosis of hyperlipoproteinemia using simultaneous determination of the lipids of the beta-prebeta lipoprotein group and of the lipid (beta and pre-beta)-cholesterol ratio].
    Girard ML, Delattre J, Legrand A, Canal J.
    Ann Biol Clin (Paris); 1973 Jan 22; 31(2):91-3. PubMed ID: 4356118
    [No Abstract] [Full Text] [Related]

  • 16. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Jan 22; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 17. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC.
    Pharmacotherapy; 1995 Jan 22; 15(3):317-37. PubMed ID: 7667166
    [Abstract] [Full Text] [Related]

  • 18. Advances in lipoprotein research: biochemical and clinical aspects.
    Schettler G, Seidel D, Greten H.
    Med J Aust; 1973 May 12; 1(19):942-6. PubMed ID: 4351788
    [No Abstract] [Full Text] [Related]

  • 19. Studies on serum lipoproteins of rats developing spontaneous hyperlipidemia.
    Gustafsson K, Kiessling H.
    Artery; 1981 May 12; 9(6):456-76. PubMed ID: 7337554
    [Abstract] [Full Text] [Related]

  • 20. Studies in asymptomatic primary hyperlipidaemia. I. Types of hyperlipoproteinaemias and serum lipoprotein concentrations, compositions and interrelations.
    Olsson AG, Carlson LA.
    Acta Med Scand Suppl; 1975 May 12; 580():1-37. PubMed ID: 170799
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.